Sotabase

Career

· Researcher, UC Berkeley AUTOLab2024–
· Uber
· Researcher, University of California, Berkeley (UC Berkeley) Autolab – Laboratory for Automation Science and Engineering

Publications (119)

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
New England Journal of Medicine · 2012
1,910
cited
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
The Lancet · 2024
1,566
cited
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
Cancer Cell · 2011
1,274
cited
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.
Blood · 2009
739
cited
The role of mutations in epigenetic regulators in myeloid malignancies
Nature Reviews. Cancer · 2012
731
cited
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.
Cancer Cell · 2012
577
cited
Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
EClinicalMedicine · 2023
521
cited
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
Leukemia · 2009
440
cited
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.
Blood · 2014
387
cited
Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias.
Cancer Research · 2010
329
cited
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
Leukemia · 2009
287
cited
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
The Lancet Haematology · 2023
286
cited
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.
Blood · 2016
282
cited
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
Leukemia · 2010
271
cited
Relapse specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
Nature Genetics · 2013
270
cited
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019
The Lancet Regional Health - Europe · 2022
258
cited
DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.
Cell Reports · 2014
256
cited
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
Leukemia · 2009
254
cited
Expert crowdsourcing with flash teams
ACM Symposium on User Interface Software and Technology · 2014
240
cited
Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome.
Blood · 2012
213
cited
Sotabase
Jay Patel | Researcher Profile | Sotabase | Sotabase